Integra Lifesciences Holdings Corp Prices $450M in Senior Secured Notes

By Bobby Samwell • Sunday, October 11 16:08 • Permanent Link

Integra Lifesciences Holdings said it priced $450 million of 9.500% senior secured notes due 2033, adding a new layer of debt as part of a broader refinancing.

The company said the notes are expected to close on or about Oct. 19, 2026. Proceeds, together with borrowings under a new credit facility, will be used to refinance existing credit facilities and cover fees and expenses tied to the transaction.

The new notes carry a 9.500% coupon and mature in 2033. They will be senior secured obligations of Integra and guaranteed by the company’s wholly owned domestic subsidiaries that already guarantee its senior secured credit facilities.

Integra did not disclose a change in the size of its existing credit facilities in the release, but said the debt sale is part of a broader refinancing transaction. As a result of these announcements, the company's shares have moved 3.15% on the market, and are now trading at a price of $13.41. For the full picture, make sure to review INTEGRA LIFESCIENCES HOLDINGS CORP's 8-K report.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.